Back to Search Start Over

Cannabinoid disposition in oral fluid after controlled smoked, vaporized, and oral cannabis administration.

Authors :
Swortwood MJ
Newmeyer MN
Andersson M
Abulseoud OA
Scheidweiler KB
Huestis MA
Source :
Drug testing and analysis [Drug Test Anal] 2017 Jun; Vol. 9 (6), pp. 905-915. Date of Electronic Publication: 2016 Oct 13.
Publication Year :
2017

Abstract

Oral fluid (OF) is an important matrix for monitoring drugs. Smoking cannabis is common, but vaporization and edible consumption also are popular. OF pharmacokinetics are available for controlled smoked cannabis, but few data exist for vaporized and oral routes. Frequent and occasional cannabis smokers were recruited as participants for four dosing sessions including one active (6.9% Δ <superscript>9</superscript> -tetrahydrocannabinol, THC) or placebo cannabis-containing brownie, followed by one active or placebo cigarette, or one active or placebo vaporized cannabis dose. Only one active dose was administered per session. OF was collected before and up to 54 (occasional) or 72 (frequent) h after dosing from cannabis smokers. THC, 11-hydroxy-THC (11-OH-THC), 11-nor-9-carboxy-THC (THCCOOH), tetrahydrocannabivarin (THCV), cannabidiol (CBD), and cannabigerol (CBG) were quantified by liquid chromatography-tandem mass spectrometry. OF cannabinoid C <subscript>max</subscript> occurred during or immediately after cannabis consumption due to oral mucosa contamination. Significantly greater THC C <subscript>max</subscript> and significantly later THCV, CBD, and CBG t <subscript>last</subscript> were observed after smoked and vaporized cannabis compared to oral cannabis in frequent smokers only. No significant differences in THC, 11-OH-THC, THCV, CBD, or CBG t <subscript>max</subscript> between routes were observed for either group. For occasional smokers, more 11-OH-THC and THCCOOH-positive specimens were observed after oral dosing than after inhaled routes, increasing % positive cannabinoid results and widening metabolite detection windows after oral cannabis consumption. Utilizing 0.3 µg/L THCV and CBG cut-offs resulted in detection windows indicative of recent cannabis intake. OF pharmacokinetics after high potency CBD cannabis are not yet available precluding its use currently as a marker of recent use. Published 2016. This article is a U.S. Government work and is in the public domain in the USA.<br /> (Published 2016. This article is a U.S. Government work and is in the public domain in the USA.)

Details

Language :
English
ISSN :
1942-7611
Volume :
9
Issue :
6
Database :
MEDLINE
Journal :
Drug testing and analysis
Publication Type :
Academic Journal
Accession number :
27647820
Full Text :
https://doi.org/10.1002/dta.2092